Table 1.
The relationship between MTUS1 mRNA expression profiles and clinicopathological parameters using data from 643 CRC patients retrieved from the TCGA database
| Characteristic | levels | Overall |
|---|---|---|
| n | 644 | |
| Age | <=65 | 276 (42.9%) |
| >65 | 368 (57.1%) | |
| Gender | Female | 301 (46.7%) |
| Male | 343 (53.3%) | |
| T stage | T1 | 20 (3.1%) |
| T2 | 111 (17.3%) | |
| T3 | 436 (68%) | |
| T4 | 74 (11.5%) | |
| N stage | N0 | 368 (57.5%) |
| N1 | 153 (23.9%) | |
| N2 | 119 (18.6%) | |
| M stage | M0 | 475 (84.2%) |
| M1 | 89 (15.8%) | |
| Pathologic stage | Stage I | 111 (17.8%) |
| Stage II | 238 (38.2%) | |
| Stage III | 184 (29.5%) | |
| Stage IV | 90 (14.4%) | |
| CEA level | <=5 | 261 (62.9%) |
| >5 | 154 (37.1%) | |
| Neoplasm type | Colon adenocarcinoma | 478 (74.2%) |
| Rectum adenocarcinoma | 166 (25.8%) | |
| OS event | Alive | 515 (80%) |
| Dead | 129 (20%) |